Expression and purification of recombinant vesicular glutamate transporter VGLUT1 using PC12 cells and High Five insect cells by Andersen, Søren S.L.
 
 
 
 
 
 
 
Biological Procedures Online • Vol. 6 No. 1 • June 7, 2004 • www.biologicalprocedures.com 
©2004. Biological Procedures Online. Published in Biological Procedures Online under license from the author(s). Copying, printing, redistribution 
and storage permitted. 
Biol. Proced. Online 2004;6(1): 105-112 
doi:10.1251/bpo78 
 
Expression and purification of recombinant vesicular glutamate 
transporter VGLUT1 using PC12 cells and High Five insect cells 
 
Søren S. L. Andersen1* 
 
1Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA 94305-5489, USA.  
 
*To whom correspondence should be addressed: Søren S. L. Andersen, Email: soren@sorenandersen1.org 
 
Submitted: April 20, 2004; Revised: May 31, 2004; Accepted: May 18, 2004; Published: June 7, 2004. 
 
Indexing terms: Membrane Proteins; Baculovirus; Glutamates.  
 
 
ABSTRACT 
 
In synaptic vesicles, the estimated concentration of the excitatory amino acid glutamate is 100-150 mM. It was recently discovered that 
VGLUT1, previously characterized as an inorganic phosphate transporter (BNPI) with 9-11 predicted transmembrane spanning 
domains, is capable of transporting glutamate. The expression and His-tag based purification of recombinant VGLUT1 from PC12 cells 
and High Five insect cells is described. Significantly better virus and protein expression was obtained using High Five rather than Sf9 
insect cells. PC12 cell expressed VGLUT1 is functional but not the Baculovirus expressed protein. The lack of functionality of the 
Baculovirus expressed VGLUT1 is discussed. The data indicate that VGLUT1 readily oligomerizes/dimerizes. The data are discussed in 
the context of developing this system further in order to reconstitute vesicular glutamate uptake in vitro using lipid-detergent vesicles. 
 
 
INTRODUCTION 
 
Synaptic communication between neurons involves the release of 
neurotransmitters at the nerve terminal through fusion of 
neurotransmitter-filled synaptic vesicles with the pre-synaptic 
membrane (1). Until the 1980’s, direct evidence for storage of 
glutamate, the major excitatory neurotransmitter in the 
mammalian CNS, in synaptic vesicles was lacking (2, 3). 
Biophysical studies have suggested that glutamate is present in 
synaptic vesicles at concentrations exceeding 100 mM (2-4). It 
has been argued that vesicles are entirely filled with glutamate, 
and in order to be equi-osmolar with the cytoplasm they would 
therefore contain 100-150 mM glutamate. However, this has 
never been directly measured, as vesicles constantly leak 
glutamate, and therefore can not be purified with their full 
glutamate content. Moreover, an additional reason the extent of 
synaptic glutamate filling is poorly studied is that the cellular 
machinery involved in vesicular filling has remained elusive (2, 5-
8). Recently, it was discovered that one protein able to transport 
glutamate into vesicles is the vesicular glutamate transporter 
VGLUT1 that had initially been characterized as an inorganic 
phosphate transporter (8-10). It is of fundamental interest to 
characterize how VGLUT1 transports glutamate across 
membranes into vesicles, and to understand what other lipid and 
protein requirements might be involved in order to load 
successfully vesicles with glutamate in vitro, and to an extent 
comparable to the (unknown) amounts found in synaptic vesicles 
in vivo. 
 
To unravel these issues, one first needs establish an ample source 
of recombinant VGLUT1 for reconstitution type experiments. 
This paper first describes the extraction and partial purification of 
VGLUT1 from PC12 cells, the latter from which the protein 
previously was successfully expressed in a functional form (9). 
However, amongst drawbacks, PC12 cells grow best on a solid Andersen 
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surface, rather than in suspension, and which greatly diminish the 
protein yield possible from this source. Thus, in order to produce 
readily high amounts of recombinant VGLUT1, the powerful 
Baculovirus expression system was attempted as an alternative to 
the PC12 cell based VGLUT1 expression. VGLUT1 was 
expressed and purified using Baculovirus, and as inspired by 
previous reports (11-16). Using two different assays for glutamate 
transport, it was found that the Baculovirus expressed VGLUT1 
was not functional to any significant extent. 
 
METHODS AND MATERIALS 
 
VGLUT1 purification from PC12 cells 
 
VGLUT1 containing PC12 vesicles were isolated as previously 
described (9). Briefly, vesicles derived from 12 14cm x 2cm plast 
plates (Nunc, Cat. No. 168381) were resuspended in 0.5 ml SH 
buffer (in mM: 10 Hepes, 310 sucrose, pH7.4) at a total protein 
concentration of 20-30 mg/ml, and stored at -80˚C. To purify 
VGLUT1, a 6xHis-tag present at the N-terminus of the C35 
VGLUT1 construct (parent VGLUT1 coding vector (9) with an 
N-terminal 6-His tag; generated by Dr. Richard Reimer) was 
used. The 6xHis-tag protein’s affinity for Talon beads (Clontech, 
cat no. 8901-1) was used as a primary purification step [Talon 
proved better than Ni-NTA magnetic agarose beads (Sigma, cat. 
No. 36111)]. Binding to and extraction of VGLUT1 from the 
Talon beads were performed in three quick and easy steps as 
follows. 1) Binding: one volume of vesicles (50 µl at 20-30 
mg/ml protein) was mixed with four volumes (200 µl) of buffer 
A (mM: 500 NaCl, 20 HEPES pH7.5, 10% glycerol, 1 Imidazole 
pH7.5, 1.2% cholate, and PMSF and peptide-protease inhibitor 
cocktail) that already contained one volume (50 µl) Talon beads 
(50 µl beads were from the stock sedimented for 1 min, 10 krpm, 
in a table top, and 1x buffer-A-washed). 
 
Fig. 1: Purification of VGLUT1 from PC12 cells. Left: Western blot of 
samples from the purification probed with polyclonal goat anti-VGLUT1 
antibody. Lo shows the material that was loaded on the gel, Ub is the material that 
didn’t bind to the Talon beads, 1W is the protein that remained after the first 
wash, El is the protein eluted from the beads, and Be is the protein that could not 
be eluted from the beads. Right: Coomassie stained gel, W is for wild-type PC12 
and VG1 is for VGLUT1 expressing PC12 cells. Ub is the amount the protein 
that didn’t bind to the beads, 3W is what came off in the third and last wash, El is 
what was eluted form the beads and Be is what could not be eluted from the 
beads.  * indicates the MW region for monomeric VGLUT1 and ** the MW 
region for oligomerized VGLUT1. The samples were resolved on 7.5% precast 
Bio-rad gels. Molecular weight markers are indicated. 
The mix was incubated on a rotating wheel for one hour at 4˚C. 
2) Washing: the Talon beads were pelleted and washed three 
times for five minutes, and using buffer A containing 15 mM 
Imidazole (pH 7.5) at 4˚C. 3) Elution: VGLUT1 was eluted from 
the beads by incubation with buffer A containing 200 mM 
Imidazole (pH 7.5) for 15-30 min at 4˚C (Fig. 1). 
 
Insect cell cultures 
 
Both High Five and Sf9 insect cells (Gibco, Cat. No. 11496-015) 
were used in this study. High Five cells (from Alex Bankovich) 
were used for virus propagation and protein expression and 
grown at 28˚C at a density of 1-7 x 106, rotating at 200-250 rpm 
in 50 ml cultures in shaker flasks in serum-free Insect-Xpress 
medium (BioWhittaker, Cat. No. 12-730Q) supplemented with 33 
µg/ml Gentamicin (10 mg/ml Gentamicin stock diluted 300x). 
Initially, Sf9 cells were used for virus production. They were 
grown at 28˚C in Sf-900 II SFM (Gibco, Cat. No. 10902-096). 
However, although the Sf9 cells were provided as “serum-free 
adapted” from the factory, it was necessary to supplement the Sf-
900 II medium with 5% Cosmic Calf Serum (HyClone, Cat. No. 
SH30087.03). Without serum addition, the cells grew either 1) 
slowly as adherent cultures, 2) stayed alive without significant 
growth in spinner flask cultures, and 3) died in shaker flask 
cultures. However, addition of 5% serum solved this problem, 
and allowed propagation and normal cell growth (18 hrs. 
doubling time) in adherent, spinner and shaker flask cultures. All 
media for growth of Sf9 cells were therefore supplemented with 
5% serum, and cultures were grown in shaker flasks rotating at 
200-250 rpm, with 50 ml culture, and with a density of 1-10 x 106 
cells/ml. The medium was also supplemented with either 
Penicillin-Streptomycin (diluted 500x; Gibco, Cat. No. 15140-
122;Penicillin at 10,000 units/ml, and Streptomycin at 10 mg/ml) 
or with 10 mg/ml Gentamicin (diluted 300x; Gibco, Cat. No. 
15710-064) stock solution. 
 
Generation of a VGLUT1 coding transfer plasmid 
 
SapphireTM Baculovirus DNA (Orbigen, Cat. No. bvd-10001) in 
combination with transfer plasmid pAcMP2 (gift from Dr. Aaron 
Schaefer) were used as tools to generate a recombinant VGLUT1 
coding Baculovirus. Thus, VGLUT1 was by a single XbaI cut 
excised from construct C35 and then ligated into the XbaI site of 
the pAcMP2 polylinker region, giving the pAcMP2-VGLUT1 
vector. The correct orientation of VGLUT1 in pAcMP2-
VGLU T1 was determin ed by a BamHI restriction digest (data 
not shown). The first 650 nt of the coding sequence were 
sequenced and verified to have the correct sequence; in this 
construct, the start ATG codon is located 40 nt down-stream of 
the XbaI site in the pAcMP2 polylinker. 
 
Preparation of VGLUT1 coding Baculovirus 
 
With the Sapphire DNA approach, a cotransfection of the coding 
plasmid with the linearized Baculovirus Sapphire DNA is the first 
step. To transfect Sf9 insect cells, 1 µg of pAcMP2-VGLUT1 was Andersen 
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mixed with 0.5 µg SapphireTM DNA (the DNA mix), and the mix 
incubated for 10 min at room temperature, after which 500 µl 
Grace’s medium (Gibco, Cat. No. 11605-094) without serum was 
added. In a different tube, 15 µl Cellfectin (Invitrogen, Cat. No. 
10362-010) was mixed with 500 µl Grace’s medium without 
serum (the Cellfectin mix). The DNA and Cellfectin mixes were 
combined (the transfection mix), and left at room temperature 
for 15-30 min during which time 5-10 x 106 Sf9 cells in log-phase 
(at 1-3 x 106/ml) were pelleted in a clinical bench centrifuge 
(speed 4) in a 50 ml Corning tube for about 5-10 min. To start 
the transfection, the pelleted cells were gently resuspended in the 
transfection mix, and this suspension incubated in a 50 ml 
Corning tube in a shaker at 27˚C for 5 hours, and with loosened 
cap for aeration, and at 200-250 rpm (to prevent cell 
sedimentation in the relatively narrow 50 ml tube). Following this 
5-hour incubation, 4 ml complete Sf9 medium with 5% serum 
was added to the cells. The days following the transfection, cell 
viability and density were monitored every day using a 
haemocytometer and 1% Trypan blue (Sigma) to stain for viable 
cells. Under optimal conditions, a total 30-60% increase in cell 
density (thus, less than one full doubling) is observed, and one 
should keep the cells at about 3 x 106/ml. Successful 
transfection/virus production was monitored by observing arrest 
of cell growth and/or cell death at later time points (after 3 to as 
many as 8 days). VGLUT1 protein expression was observed by 
Western blotting, and peaked at about day 5 post transfection 
(Fig. 2). However, it proved more difficult to obtain virus from 
this transfection supernatant for virus amplification (see next 
section). 
 
 
Fig. 2: Transfection and Baculovirus expression of VGLUT1. For 
Baculovirus production, Sf9 cells were co-transfected with linearized Baculovirus 
DNA (Orbigen) and the pAcMP2 transfer vector. 5 µl Culture supernatant was 
loaded on a gel at the days indicated. In the control (c), a XylE coding plasmid 
(Orbigen) was used; expression of VGLUT1 is observed after three days but is 
absent in the control transfected line at any time. * indicates the MW region for 
monomeric VGLUT1 and ** the MW region for the oligomerized VGLUT1. 
Note: virus was not detected in the transfection supernatant until seven days after 
transfection. 
A PCR assay for detection and titration of 
recombinant Baculovirus 
 
In order to detect recombinant virus production, an assay was 
developed where the supernatant from the transfection step was 
harvested and PCR-screened for the presence of VGLUT1-
containing virus/DNA sequence. This approach was adopted, as 
propagation of the virus from the 3-5 day transfection 
supernatant failed, and screening of more time points was found 
necessary. 
 
Fig. 3: Titration and propagation of VGLUT1 Baculovirus. (A) VGLUT1-
containing Baculovirus culture supernatant was added to Sf9 cells at the (III) 
1/100, (II) 1/333, and (I) 1/1000 fold dilutions indicated. 2 days (2d;black 
numbers on gel) after infection virus could by PCR be detected with the (II) 
1/333- and the (III) 1/100 but not at the (I) 1/1000 dilution. Virus production 
plateaued after 2 days and didn’t appear to increase further. Con is a PCR reaction 
made with the transfer plasmid harboring VGLUT1, and the lane to its left is the 
PCR product from the VGLUT1 containing culture supernatant used in this 
propagation assay at the three indicated dilutions (I, II, III). (B) In a comparison 
of various conditions of VGLUT1 Baculovirus amplification, it was found that by 
using High Five cells, significantly more VGLUT1-Baculovirus was amplified 
(lane 4; H5=>1/1000) using an initial 1/1000 virus dilution than with any other 
Sf9 cell condition (the remaining lanes). Prior to using the High Five cells, the 
virus was attempted concentrated by centrifugation at 45 krpm, SW50 rotor, for 
60 min at 4˚C. Lane 3 is the supernatant, and shows that no virus was left after 
centrifugation (lane 1 is the PCR product derived from the pellet fraction). 
 
For the PCR reaction, 200 µl culture supernatant was mixed with 
20 µl 20 mg/ml proteinase K (for removal of the viral capsid), 
incubated for 30 min at 37˚C, and the solution applied to Qiagen 
PCR purification kit (or DNA gel extraction kit) columns in 
order to purify the potential recombinant viral DNA (it was 
found unnecessary to shear the DNA prior to addition on the 
columns). Of the 10 µl volume eluted from the Qiagen columns, 
5 µl were used in standard 30 cycle Taq-polymerase PCR 
reactions. The 5’ and 3’ VGLUT1 primers used were at the 500 
bp and 1200 bp coding region of VGLUT1 respectively, and 
generated a PCR fragment with a predicted size of approximately 
700 bp. With this appoach, the first significant amount of virus in 
the Sf9 transfection-supernatant was not detected before day 
seven after transfection (data not shown), and explaining the 
failure to propagate virus using shorter (3-5 days) incubations 
(such long incubations are at times required; Dr. Charles Parnot, 
personal communication). The supernatant of the transfection Andersen 
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supernatant was thus harvested seven days post transfection, and 
the virus amplified once by infection of High Five cells grown in 
serum-free Insect-Xpress medium (15). To amplify the virus, the 
transfection supernatant was at three different dilutions (1/100, 
1/333, 1/1000) used to infect fresh insect cells, and virus 
containing supernatant harvested 40-48 hours after infection (Fig. 
3A). High Five cells were used, as they proved significantly better 
at producing soluble virus than Sf9 cells (Fig. 3B). 
 
VLGUT1 purification from insect cells 
 
Initially, protein was sought expressed using Sf9 cells. However, 
High Five cells grown in serum-free Insect-Xpress medium 
proved to give several orders of magnitude better protein 
expression (data not shown), and all data described here were 
obtained using High Five cells grown in serum-free Insect-
Xpress medium. The High Five cells were grown as 50 ml batch 
cultures in shaker flasks, and infected at a density of 1-3 x 106, 
and using a 1/1000 dilution of the one-time propagated 
VGLUT1-hosting Baculovirus. Protein expression was detectable 
by Western blot after about 20 hours (Fig. 4). Longer 
incubations, or use of the virus at less than a 1/500 dilution, 
caused significant cell death (the virus pfu was not determined). 
At between 40 to 48 hours post infection, cells were harvested by 
pelleting for 5-10 min. The cell pellet was resuspended in SH (in 
mM: 310 Sucrose, 10 Hepes pH7.4) in 1/10th the culture volume. 
The cells were lyzed on ice either by tip sonication for 30x1 
second or by passage 5-10 times through a ball-bearing cell 
cracker (EMBL, Heidelberg, Germany). 
 
Fig. 4: Purification of VGLUT1 from High Five cells. Left: PC12 shows for 
comparison protein from PC12 cells (Note: 200x more PC12 than High Five total 
protein was loaded), d1 is culture supernatant 1 day after infection, d2 is culture 
supernatant 2 days after infection. Load is what was loaded onto the Talon beads 
following extraction with maltopyranoside, undi is the material that was 
undisolved after detergent extraction (note: 40x more loaded than in the other 
lanes), unb is what didn’t bind the beads, 1w is what came off the beads in the first 
wash, elu is what eluted from the beads and bea is what still remained on the beads 
after dilution. Right: A Commassie gel of the purification of VGLUT1 from the 
High Five cells; c is using membranes from control infected (BVC53 virus) and v1 
membranes from VGLUT1 infected cells. L is the material loaded on the beads, 
Ub is the material that didn’t bind the beads, 3W is the material that came off in 
the third and last wash, E is what was eluted from the beads. Double arrow head 
indicates the region of migration of VGLUT1, and on the Commassie gel, no 
major band can be assigned as the recombinant VGLUT1. 
 
The suspension was centrifuged in 1.5 ml Eppendorf tubes and 
at 10 krpm, 4˚C, 10 min. After the first centrifugation, a large 
pellet is obtained which consists of a mix of membranes, and 
with a fairly clear supernatant. In order to wash the pellet 
fraction, it was twice resuspended in the same volume of SH, and 
re-pelleted. After the last centrifugation, the pellet was 
resuspended in 1/5th-1/10th the cell lysis volume (or 0.5-1 ml), 
and the pellet stored at -80˚C. Using the PC12 cell VGLUT1 
purification protocol, it proved impossible to extract any 
VGLUT1 from the insect cell membranes using Cholate or 
CHAPS (data not shown). By replacing CHAPS/Cholate with 
1% Decyl-β-maltopyranoside (Anatrace #D322S), and incubating 
for 60-90 min, it was possible to extract VGLUT1 from the pellet 
(Fig. 4), and to continue with the purification as described for the 
PC12 protein. Note: for both the PC12 and the insect cell 
purifications, the amount of detergent can be lowered to 0.5% 
during the washing step which saves reagents. 
 
Testing the functionality of insect cell expressed 
VGLUT1 
 
To test whether the Baculovirus expressed VGLUT1 was 
functionally active for glutamate transport, the assay previously 
described (9) was used. Using this assay, PC12 derived VGLUT1 
vesicles over a 2 min assay time accumulated 2-10 fold more 3H-
Glutamate than control PC12 vesicles (data not shown). In the 
experiments reported in Figure 5, where Baculovirus infected 
membranes were used, both ATP and Valinomycin (in 
combination with high potassium) were simultaneously applied. 
The assay time was 2 min, and longer incubations did not alter 
the results (data not shown). The buffer used in these 
experiments contains (in mM: 125 KSO4, 4 KCl, 4 MgCl2, 10 L-
Aspartate, 0.4 L-Glutamate, 1 ATP, 1/100 3H-Glutamate [NEN] 
and 1/200 Valinomycin (20 µM final). 
 
Fig. 5: 3H-glutamate transport assay with Baculovirus infected High Five 
cell membranes. 30 µl of the crude membranes from VGLUT1 or BVC53 
infected cells were used per reaction in a transport assay where ATP, 
Valinomycin, and 125 mM potassium sulfate were applied to the outside (see 
materials and methods). (1) shows the 3H-glutamate counts obtained at the zero 
time point, (2) shows the counts obtained after 2 min (note the identical response 
for VGLUT1 and BVC53 infected cells), and (3) is the 2 min control time point, 
where Nigericin was included in the buffer (n=2). Note that little, if any (non-
specific binding increases with time), uptake occurs between the zero and the two 
minute time point, and that there is no difference between the samples with and 
without Nigericin. 
 
In the control reaction, Nigericin (5 µM final) was added and 
ATP omitted. Aspartate was included to reduce non-specific Andersen 
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binding, and the 0.4 mM cold glutamate (as opposed to the 0.1 
mM used by (9)) was used to partially block potential high-
affinity plasma-membrane glutamate transporters (the Km of 
VGLUT1 for glutamate is about 2 mM (9)). A Baculovirus 
coding for the β-adrenergic 2 receptor (BVC53; gift from Dr. 
Charles Parnot) was used for control infections. For the 
exchange experiment (Fig. 6), the cells were pelleted and 
resuspended in 28˚C medium containing 1/50 3H-glutamate 
(NEN), 10 mM L-Aspartate and 0.5 mM cold glutamate. For 
each time point, 50 µl of this cell suspension (at about 5 x 106 
cells/ml) was diluted with 1 ml c o l d  w a s h  b u f f e r  ( 1 1 0  m M  
Tartrate), and the solution immediately applied onto a 
nitrocellulose filter (0.65 µm DAWP, Millipore; (12)) followed by 
two washes with 2.5 ml cold Tartrate buffer. 
 
Fig. 6: 3H-glutamate exchange assay with intact Baculovirus infected High 
Five cells. Intact High Five cells were incubated in culture medium with 3H-
glutamate. After the time indicated (minutes), the cells were isolated on a 
membrane, washed with buffer and subjected to Scintillation counting. Columns 
are VGLUT1 (left) infected and CONT/BVC53 (right) infected cells respectively; 
the left graph shows uptake 1 day after infection, and the right graph uptake 2 
days after infection (n=2). 
 
RESULTS 
 
Purification of VGLUT1 from PC12 cells 
 
In order to further characterize VGLUT1, stable transfectants of 
VGLUT1-harboring PC12 cells (9) were used for the 
development of an easy and fast purification protocol. The 
protocol has three steps: 1) solubilization and binding to metal 
beads, 2) washing, and 3) elution (Fig. 1). A Histidine tag on 
VGLUT1 was used for the affinity purification, and the N-
terminally His-tagged protein gave better purification results than 
the equivalent C-terminally tagged protein (both proteins are 
equally functionally active; data not shown). All results reported 
here were therefore performed using the N-terminally tagged 
protein. To extract VGLUT1 from the membrane, vesicles were 
resuspended in a buffer containing 1.2% Cholate (or 1.2% 
CHAPS), and then immediately mixed with Talon beads. 
Following washing, associated proteins were eluted with 
Imidazole (Fig. 1). Roughly 50% of the total amount of 
VGLUT1 was bound to the beads, and most of that protein 
came off during the elution step (Fig. 1). Talon beads, which 
employ Cobalt to chelate the His-tag, were used for the affinity 
purification as trial experiments proved them better than Ni-
based beads (data not shown). In particular, with the Ni-based 
beads, a lot of protein could not be eluted whereas the Co-based 
beads allowed elution of associated VGLUT1 much more readily 
(data not shown). Interestingly, although gel samples were 
prepared at room temperature (as opposed to boiling) in standard 
Laemmli buffer (containing SDS and β-mercaptoethanol), a band 
roughly in the region of 140-160 kD (twice that of monomeric 
VGLUT1) was reproducibly observed on Western blots, and 
suggesting that VGLUT1 readily forms oligomers/dimers (Fig. 
1A, marked with two stars). Boiling of the samples for 1-2 min 
prior to gel loading did not decrease or increase the amount of 
the 140-160 kD band, but rather diminished the detectable 
amount of VGLUT1, and thus indicating that even higher 
oligomeric forms/aggregates were generated (data not 
shown;note smear at the top of the gel). The amounts of protein 
eluted from the beads did not, compared with the control cells, 
allow specific assignment of a band on the gel to VGLUT1 (Fig. 
1B), and indicating that the expression levels and amounts of 
VGLUT1 obtainable from PC12 cells is moderate. Indeed, for 
the generation of 50 µl VGLUT1 containing vesicles (at 20-30 
mg/ml total protein) used in this purification, all cells from 2 
tissue culture plates (about 2 x 107 cells;using a total of 40 ml 
medium) were the starting material. Therefore, as previous 
reports have demonstrated functional membrane protein 
expression using insect cells, the reagents required for 
Baculovirus expression of VGLUT1 were generated. 
 
Baculovirus expression of VGLUT1 
 
The state-of-the art approach for production of recombinant 
Baculovirus involves the co-transfection of a piece of linearized 
Baculovirus DNA with a transfer plasmid harboring the gene of 
interest. Reportedly, more than 90% of the virus produced using 
this method is recombinant, and no cumbersome screening steps 
are required (http://www.orbigen.com). After the transfection, 
VGLUT1 protein expression could be detected by Western 
blotting after 3 days, whereas control transfected cells (XylE 
control from Orbigen) didn’t show any VGLUT1 expression 
(Fig. 2). Interestingly, the protein expressed after transfection 
migrated at lower molecular weight (about 50 kD) than the 
protein from PC12 cells (Fig. 1; discussion). Initial attempts at 
propagating recombinant virus using the supernatant from 5 day 
old cells proved unsuccessful (data not shown). Consequently, to 
more readily detect the presence of virus in the culture 
supernatant, a PCR-based detection approach was developed. 
Recombinant VGLUT1 virus was not observed earlier than 7 
days after transfection (data not shown), and explaining the 
failure to propagate vira from earlier time points. During this 
amplification process, it was discovered that the recombinant 
virus was much better amplified using High Five cells grown in 
serum free InsectXpress medium than using Sf9 cells (Fig. 3B). 
Following this observation, all subsequent experiments were 
performed using High Five cells grown in serum free 
InsectXpress medium. To propagate the virus, transfection 
supernatant were at three different dilutions used to infect insect 
cells, and virus harvested 40-48 hours after infection (Fig. 3A). 
The virus from the amplification was titered by observing the Andersen 
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viability of the infected High Five cells. It was found that at a 
1/1000-fold virus dilution, very good protein expression and cell 
viability was obtained. Cells were for protein purification 
harvested 40-48 hours after infection. 
 
Purification of VGLUT1 from High Five cells 
 
VGLUT1-Baculovirus infected cells were harvested by 
centrifugation, and lysed at 4˚C by brief sonication or with a cell 
cracker. Crude membranes were prepared by pelleting the lysed 
cells at 4˚C, at 10,000-20,000 g for 15 min (12). Most of 
VGLUT1 was observed in the pellet/crude membrane fraction, 
and little in the supernatant (data not shown). Using these crude 
membranes as starting material, and in order to purify VGLUT1 
from the High Five cells, the protocol developed for use with the 
PC12 cells was initially applied. However, it proved impossible to 
extract any VGLUT1 from the insect cell membranes using 
Cholate or CHAPS (data not shown), and no protein was found 
bound to the Talon beads using these conditions (data not 
shown). Previous accounts on Baculovirus-expression of 
membrane proteins have indicated that Cholate (or CHAPS) 
extract poorly proteins from insect cell membranes (14). Guided 
by these observations (14), by substituting Cholate/CHAPS with 
1% n-decyl-β-d-maltopyranoside, and using otherwise identical 
conditions to those used for the PC12 based purification, it was 
found possible to extract VGLUT1 from the insect cell 
membranes (Fig. 4). However, even after a 90 min extraction, a 
significant amount of insoluble material remained, which a 
western blot showed contained significant amounts of VGLUT1, 
and thus indicating that the protein was aggregated already prior 
to the detergent extraction (Fig. 4). 
 
Testing the functionality of Baculovirus expressed 
VGLUT1 
 
To test whether VGLUT1 expressed in the insect cells was 
functionally active, the assay used with PC12 cell vesicles was 
applied (9). In this assay, vesicular VGLUT1 containing 
membranes are incubated in a buffer containing 3H-glutamate 
and ATP, and 3H-counts 2-10 fold over control vesicles is 
routinely observed (data not shown; (9)). The energy for 
transport of glutamate across the membrane is derived from ATP 
hydrolysis (10). ATP is hydrolyzed by the proton-ATPase, 
located in the vesicular membrane, and the protons transported 
inside the vesicles give rise to a proton-electrochemical gradient 
that serves as the driving force for the vectorial transport of 
glutamate into the vesicles. Alternatively, Valinomycin (17) and a 
high extra-vesicular concentration of potassium can be used in 
order to generate a driving force. Valinomycin makes the 
membranes vectorially, and uni-directionally, permeable for 
potassium, and for a few minutes, the potassium gradient 
imposed by the high external potassium concentration, as 
opposed to the zero intravesicular potassium, can serve as driving 
force for glutamate transport across the membrane. In the 
presence of Valinomycin, the reagent Nigericin, which makes the 
membrane bi-directionally permeable for potassium ions, is used 
as a control in order to demonstrate that glutamate uptake is 
dependent on the potassium gradient. The Valinomycin approach 
is of interest in case it is uncertain the membranes tested contain 
a proton-ATPase, or as an additional tool to show that glutamate 
uptake is VGLUT1 dependent. In order to test for the uptake of 
glutamate/3H-glutamate, and as it is was not known whether the 
crude High Five membrane fraction contained a proton ATPase, 
both ATP and high potassium/Valinomycin were added to the 
assay. In the experiments using membranes from VGLUT1-
Baculovirus infected insect cells, no difference in 3H-glutamate 
counts compared with the control β-adrenergic 2 receptor virus 
infected cells were observed (Fig. 5). Moreover, the absolute 
increase in counts was minimal (an increase in total counts over 
time is always observed due to non-specific 3H-glutamate 
binding). These data indicate that High Five VGLUT1 containing 
cell membrane fractions do not harbor a functional VGLUT1 
transporter. Because of the overexpression of VGLUT1 it is 
likely that some of the protein could get transported/mislocalized 
to the plasma membrane where it could be present in a functional 
form. In order to test that idea, a passive 3H -glutamate exchange 
reaction assay was performed. In this assay, the cells are allowed 
to freely equilibrate and exchange intracellular glutamate with 
extracellular 3H -glutamate. If functional VGLUT1 were localized 
on the cell surface, one would expect such cells to take up more 
glutamate than control infected cell. As shown in Figure 6, no 
difference in passive glutamate uptake, as compared to control 
infected cells, were observed either one day or two days post 
infection. The one day time point was included as a previous 
report on SERT suggested that the insect cells become too leaky 
for uptake if infected for more than 20-36 hours (12). In 
summary, the data suggest that VGLUT1 expressed in High Five 
insect cells is not functional (Figs. 5 and 6). 
 
DISCUSSION 
 
Expression of VGLUT1 in insect cells 
 
Roughly 100-200-fold more VGLUT1 protein/total protein was 
obtained with Baculovirus expression as compared to PC12 cell 
expression, but while VGLUT1 expressed in PC12 cells is active, 
that did not appear to be the case for the Baculovirus expressed 
protein. That VGLUT1 expressed in insect cells appears inactive 
is intriguing but not surprising. Previous reports provide mixed 
evidence that Baculovirus expressed membrane proteins indeed 
are active, and some reports claim functionality based on the 
mere binding of an inhibitor to the protein, and without 
demonstrating actual functionality (11-16). I hypothesize that the 
modest amount of ER and Golgi apparatus in insect cells, 
combined with the over-expression obtained by the Baculovirus, 
are grounds for the absence of activity observed, as the little 
membrane volume probably rapidly gets filled/aggregated with 
the recombinant VGLUT1’s 9-11 transmembrane spanning 
domains. The detergent extraction data also indicate that a lot of 
the protein is already aggregated and that the remainder is 
difficult to extract from the membranes (confirming previous 
observations (14)) as compared with PC12 cells. Lack of Andersen 
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glycosylation has been implicated as a cause for lack of 
Baculovirus expressed membrane protein activity (16). However, 
while PC12 VGLUT1 on the SDS-PAGE gels smears as a typical 
glycoprotein, expression with Baculovirus gives rise to three 
distinct bands as opposed to the one band one would expect if 
the protein were not at all glycosylated (the low molecular weight 
of the protein obtained in the transfection step may be explained 
by the lack of posttranslational modifications). Further studies 
will be required to determine whether (correct) glycosylation of 
VGLUT1 is required for functionality. Apart from glycosylation, 
lack of proteinatious (other subunits) or other non-proteinatious 
factors (i.e. cholesterol) could explain/add to the lack of activity. 
Obviously this study is not an exhaustive analysis of all the 
parameters that could be changed in the quest for obtaining 
functional protein, for example different promotors, and it 
remains a possibility that conditions can be determined where 
functional protein is obtained from over-expression in insect 
cells. However, I hypothesize that it seems most plausible that 
insect cells are simply not optimal for expression of membrane 
proteins (in particular not with as many as 9-11 transmembrane 
spanning domains) because of their modest content of 
intracellular endoplasmatic reticulum and Golgi membranes, and 
cautions to rely on Baculovirus-based expression systems for the 
over-expression of functional multi-membrane spanning 
membrane proteins. 
 
By Western blotting, a prominent band at a molecular weight 
twice (140-160 kD) that of monomeric (70-80 kD) VGLUT1 is 
observable for both the PC12 and Baculovirus expressed protein 
(Figs. 1, 2, and 4; (8)). Moreover, while the samples were 
prepared at room temperature in standard Laemmli buffer 
(containing SDS and β-mercaptoethanol), if the samples were 
boiled prior to loading on the gel, even more extensive 
aggregation occurred (data not shown), and supporting that 
VGLUT1 has a strong tendency to oligomerize. This data 
indicate that the active transporter might function as a 
(homo)dimer, and I suggest they support a dimer-hypothesis 
previously proposed for amine transporter proteins (5). 
 
Reconstitution of vesicular synaptic glutamate 
uptake 
 
A primary goal of the experiments described here is to fully 
reconstitute glutamate filling of synaptic vesicles from purified 
components. The concentration of the excitatory amino acid 
glutamate in synaptic vesicles is estimated at a 100-150 mM 
concentration (2). However, this has for technical reasons never 
been directly measured. It appears it should soon be possible to 
use fluorescently labeled glutamate to measure directly the 
vesicular glutamate content in vivo. The amount of glutamate in 
synaptic vesicles is of fundamental importance for the regulation 
of the size of the post-synaptic response elicited by the release of 
a single synaptic vesicle at the pre-synaptic membrane (the 
quantal size; (3)). Glutamate containing lipid-detergent vesicles 
can be prepared using crude soybean phospholipids (18), a 
glutamate containing solution, the detergent β-octylglucoside, 
and, for detergent removal, gel filtration spin columns ((19); 
Andersen SSL, unpublished data). Preliminary experiments using 
this preparation, and based on direct NADP/NADPH-based 
fluorimetric measurements (20), indicate that at physiological pH 
7.4, the maximal obtainable glutamate-filling of the pure vesicles 
is reached using a buffer containing 50 mM glutamate. Higher 
concentrations of glutamate (120 mM) did not increase (or 
decrease) the amount of glutamate trapped in the vesicles, and I 
suggest this indicates that the upper limit for vesicular glutamate 
content may be in the 50 mM range rather than in the estimated 
100-150 mM concentration range (Andersen SSL, unpublished 
data). It will be interesting to continue further with the 
characterization of these pure lipid-detergent vesicles, and further 
expand the system by incorporating pure VGLUT1. However, 
rather than attempting to obtain sufficient VGLUT1 from PC12 
cells, in a first instance VGLUT1 could be obtained from calf 
brains where it is very abundant (18). Once lipid-detergent 
VGLUT1 containing vesicles have been reconstituted using calf 
brain VGLUT1, the use of recombinant/mutated VGLUT1 from 
PC12 cells, or other source, will be required to further address 
mechanistic questions. For reconstitution, it will also be required 
to add a pure proton ATPase to the system. The proton ATPase 
may for reconstitution purposes be obtained as a side-fraction 
from the calf brains, or replaced by Bacteriorhodopsin (7) or 
omitted and replaced by Valinomycin and a potassium gradient. 
Reconstitution of the filling of synaptic vesicles with glutamate 
will in this manner be build up from purified components, and 
will provide fundamental answers both to the concentration-
range of glutamate in synaptic vesicles and to the mechanisms of 
vesicular glutamate uptake/transport (6). 
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